(R)-Acenocoumarol is a short-acting oral anticoagulant that exerts its effect by inhibiting vitamin K epoxide reductase; it demonstrates higher intrinsic anticoagulant potency than warfarin and phenprocoumon in vitro; it exhibits stronger anticoagulant activity in vivo compared to its (S)-enantiomer.